Top Journalists in Biotechnology
Annalee Armstrong BioSpace
Senior editor at BioSpace covering biotech companies, leadership trends, and industry policy; previously senior editor at FierceBiotech. Specialties: Biotech industry trends, executive moves, FDA, gender & leadership, conference coverage
Max Bayer Endpoints News
Pharma reporter at Endpoints News focusing on FDA developments, clinical data, and industry restructuring; previously at Fierce Biotech and CBS News. Specialties: Pharma and biotech news, FDA policy, vaccines, restructuring/M&A
Jacob Bell BioPharma Dive
Senior reporter at BioPharma Dive covering biopharma pipelines, FDA decisions, and company strategy. Specialties: Drug R&D, FDA decisions, company strategy, neuroscience
Zachary Brennan Endpoints News
Senior editor at Endpoints News leading U.S. regulatory coverage with a focus on FDA and global regulators; formerly at POLITICO and RAPS. Specialties: FDA/regulatory policy, Capitol Hill, public health
John Carroll Endpoints News
Co-founder and editor of Endpoints News, longtime biotech editor and industry analyst known for agenda-setting daily coverage. Specialties: Industry news, executive moves, clinical/R&D pipeline, analysis
Elaine Chen STAT
National biotech reporter at STAT; co-writes The Readout newsletter and co-hosts The Readout LOUD podcast, with a focus on metabolic and biotech news. Specialties: Biotech companies, obesity/metabolic drugs, The Readout newsletter and podcast
Allison DeAngelis STAT
Biotech startups and venture capital reporter at STAT and co-host of The Readout LOUD; covers where scientific ideas meet money. Specialties: Startups, venture capital, biotech financing, M&A
Adam Feuerstein STAT
Senior biotech writer and columnist at STAT; co-host of The Readout LOUD and author of Adam’s Biotech Scorecard newsletter. Specialties: Drug development, Wall Street, FDA, biotech equities
Damian Garde Bloomberg News
Reporter at Bloomberg News covering pharma/biotech; previously national biotech reporter and Readout co-author at STAT. Specialties: Big pharma and biotech, deals, pipeline and policy intersections
Jonathan Gardner BioPharma Dive
Senior reporter at BioPharma Dive covering FDA decisions, late-stage data and policy that shapes the drug industry. Specialties: Regulatory approvals, late-stage clinical data, policy impacts
Max Gelman Endpoints News
Senior editor at Endpoints News writing on big-picture trends in biopharma, with interests in immunology and neuroscience. Specialties: Clinical R&D trends, immunology, neuroscience, weekly analysis
Hannah Kuchler Financial Times
Global pharma editor/correspondent at the Financial Times leading science and pharma coverage across markets. Specialties: Global pharma/biotech business, obesity drugs, M&A, policy
Heidi Ledford Nature
Science reporter at Nature focusing on biomedicine and biotechnology with deep expertise in genetics and R&D. Specialties: Biomedicine, genetics, drug development science, biotech policy
Robert Langreth Bloomberg News
Reporter-at-large at Bloomberg News covering science and health, including major biopharma pipelines and regulatory decisions. Specialties: Drug pipelines, FDA approvals, obesity/Alzheimer’s, pharma deals
Peter Loftus The Wall Street Journal
Reporter at The Wall Street Journal covering pharmaceuticals, biotech and medical devices; author of The Messenger about Moderna. Specialties: Pharma/biotech business, vaccines, medical devices, FDA
Emily Mullin WIRED
Staff writer at WIRED covering biotechnology and its societal implications; previously at MIT Technology Review and OneZero. Specialties: Biotechnology and society, gene editing, neurotech, synthetic biology
Ned Pagliarulo BioPharma Dive
Lead editor at BioPharma Dive steering coverage of biotech pipelines, FDA moves, and dealmaking. Specialties: Industry news, M&A, FDA policy, pipelines, earnings
Antonio Regalado MIT Technology Review
Senior editor for biomedicine at MIT Technology Review, reporting on how emerging technologies are transforming medicine and research. Specialties: Cutting-edge biomedicine, genomics, bioethics, AI in biology
Kate Sheridan STAT
Research reporter at STAT; previously covered biotech startups and venture capital, now digs into data and documents across biotech and science. Specialties: Biotech research, VC/startups, data/document analysis
Related Topics
Further Reading
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.